SCHEMBL7731479

SCHEMBL7731479

CC(C)(C)OC(=O)N1C[C@H](N(C(=O)CN)C(=O)OC(C)(C)C)C[C@H]1C(=O)Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 5/20 0.44
NPC1 O15118 1/20 0.42
PABPC1 P11940 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
CFTR P13569 1/20 0.41
NPY5R Q15761 2/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HTRA1 Q92743 1/20 0.39
GHSR Q92847 1/20 0.39
CYP1A2 P05177 1/20 0.39
POLB P06746 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7727754 0.92 POLB (0.44) HDAC8NPC1MEN1KMT2ACFTR
SCHEMBL7731725 0.91 HDAC8 (0.44) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7727252 0.90 KDM4E (0.46) HDAC8NPC1ALDH1A1SMN1; SMN2GHSR
SCHEMBL7726523 0.90 HDAC8 (0.41) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7728192 0.88 POLB (0.47) HDAC8NPC1MEN1KMT2AALDH1A1
SCHEMBL7725709 0.88 NPC1 (0.43) HDAC8NPC1MEN1KMT2AHTRA1
SCHEMBL7728833 0.85 SIRT2 (0.47) HDAC8GHSRPOLB
SCHEMBL7722105 0.82 PTPN1 (0.40) HDAC8NPC1PABPC1KMT2AHTRA1
SCHEMBL7728565 0.81 MEN1 (0.51) HDAC8NPC1PABPC1MEN1KMT2A
SCHEMBL7728568 0.81 MEN1 (0.51) HDAC8NPC1PABPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed